This mdr is created as a follow-up to record (b)(4), initially reported on product code otn asr exemption # e2014015 for april-may 2018.This mdr is to reflect the additional information to be added to the initial asr report.(patient age, product information, corrected implant date).The lot number was reviewed for complaint trend, nonconforming report and capa review.No trends were noted.
|
Additional information, reported to coloplast though not verified, indicated urinary retention, pain, fever, nausea, vomiting, fatigue, uti, hip pain, flank pain, trouble urinating, urinary frequency, urinary urgency, tenderness, right groin incision, vaginal pain, questionable blood clot in bladder, dysuria, uti, incomplete emptying, nocturia, incontinence, dyspareunia, bleeding after intercourse, urethra tender over sling, sui.(b)(6) 2017 - diagnostic cystoscopy, vaginal exploration with removal of the right arm of mid urethral sling, urethrolysis, and groin exploration under ga, passing blood clots.
|